INTERNATIONAL PATENT: JANUX THERAPEUTICS, INC. FILES APPLICATION FOR "ANTIBODIES TARGETING STEAP-1 AND CD3 AND USES THEREOF"

GENEVA, April 21 -- JANUX THERAPEUTICS, INC. (10955 Vista Sorrento Parkway, Suite 200San Diego, California 92130) filed a patent application (PCT/US2024/050265) for "ANTIBODIES TARGETING STEAP-1 AND CD3 AND USES THEREOF" on Oct 07, 2024. With publication no. WO/2025/080533, the details related to the patent application was published on Apr 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CAMPBELL, David (10955 Vista Sorrento Parkway, Suite 200San Diego, California San Diego), DIRAIMONDO, Thomas R. (10955 Vista Sorrento Parkway, Suite 200San Diego, California San Diego), LAUDENSLAGER, John...